recombinant human papillomavirus quadrivalent vaccine (ree-KOM-bih-nunt HYOO-mun PA-pih-LOH-muh-VY-rus KWAH-drih-VAY-lent vak-SEEN)
A vaccine used to prevent anal, cervical, vulvar, and vaginal cancer caused by human papillomavirus (HPV) types 16 and 18 and genital warts caused by HPV types 6 and 11. Recombinant human papillomavirus quadrivalent vaccine is approved for use in males and females aged 9 to 26 years. It is a type of quadrivalent vaccine (a vaccine that works against four different viruses or other microorganisms). Also called Gardasil.